A Phase III Clinical Trial of PROCRIT (Epoetin Alfa) Versus Placebo in Women Undergoing Adjuvant Chemotherapy for Stage I, II or III Breast Cancer
Phase 3
Terminated
- Conditions
- AnemiaBreast NeoplasmsHemoglobinsQuality of LifeChemotherapy, Adjuvant
- First Posted Date
- 2005-10-30
- Last Posted Date
- 2011-05-19
- Lead Sponsor
- Ortho Biotech Products, L.P.
- Target Recruit Count
- 37
- Registration Number
- NCT00246597
Dosing and Outcomes Study of Erythropoietic Stimulating Therapies in Patients With Chemotherapy Induced Anemia
Completed
- Conditions
- AnemiaCancer
- Interventions
- Other: Patients with chemotherapy induced anemia
- First Posted Date
- 2005-09-21
- Last Posted Date
- 2014-06-30
- Lead Sponsor
- Ortho Biotech Products, L.P.
- Target Recruit Count
- 2130
- Registration Number
- NCT00212862
Open-Label Extension Safety Study of PROCRIT in Patients With Anemia of Chronic Disease Due to Rheumatoid Arthritis
Phase 2
Withdrawn
- Conditions
- AnemiaRheumatoid Arthritis
- First Posted Date
- 2005-07-22
- Last Posted Date
- 2016-09-20
- Lead Sponsor
- Ortho Biotech Products, L.P.
- Registration Number
- NCT00123149
© Copyright 2025. All Rights Reserved by MedPath